Breast Imaging Market 2022 Top Leading Countries, Companies, Consumption, Drivers, Trends Analysis, Revenue, Challenges and Global Forecast 2030

AI and ML Create Lucrative Opportunities for Early Detection of Lesions

AI (Artificial Intelligence) and ML (Machine Learning) are virtually penetrating almost all industries, including healthcare. These technologies are generating incremental opportunities for companies in the breast imaging market. The alarming rate of women in the U.S. that may be susceptible to breast cancer during their lifetime has led to the adoption of AI and ML to improve patient quality of life. The market in the U.S., one of the major economies of North America, is anticipated to generate the highest revenue and is predicted for exponential growth. There is a growing need for early detection and increased awareness among patients in the market for breast imaging.

Get the sample copy of report@

Early detection of lesions with the help of AI and ML has helped to improve clinical numbers. This phenomena is being further leveraged with advanced screening mammography, whereas this technique is gaining global recognition as one of the most effective methods for detecting early breast cancer. This explains why ionizing breast imaging dictates the highest revenue among all technologies in the breast imaging market.

Digital Breast Imaging and Patient Communication Improve Clinical Outcomes

Early cancer detection has become one of the important prerequisites for most women worldwide. Hence, healthcare companies are gaining expertise in digital breast imaging to improve cancer diagnosis. Such advancements are boosting the revenue of breast imaging market, which is estimated to be valued at ~US$ 7 Bn by the end of 2028. On the other hand, clinicians are building their credibility by gaining efficacy in FDA-approved technologies for breast imaging. Such technologies are supporting a wide range of clinical research studies and the development of innovative products related to breast cancer.

Get a glimpse of the in-depth analysis through our Report Brochure

Apart from innovations in the breast imaging market, clinicians are creating an awareness about radiologist-patient communication as the key to offer a more patient-centric atmosphere in hospitals and clinics. Thus, along with innovations in breast imaging, healthcare providers need to understand that patients are more willing to interact with their radiologist, while being educated about their individual circumstances.

DBT Outperforms DM in Detection of Poor Prognosis Cancers

Advantages offered by tomosynthesis are anticipated to outperform the offerings of digital mammography. However, in the current scenario, the rapidly evolving COVID-19 (Coronavirus) has forced stakeholders to cancel and reschedule important conferences associated with breast imaging. For instance, the 2020 Society of Breast Imaging/American College of Radiology (SBI/ACR) annual symposium has been cancelled and rescheduled for April 8 – April 11, 2021, in Savannah, Georgia, U.S. Such unwelcome pandemics are slowing down the pace of innovations in the breast imaging market. Hence, healthcare companies are taking cues from previous and ongoing research materials available at their disposal.

View full report@

Newly published studies are offering important insights to technology companies that are shifting their focus to digital breast tomosynthesis (DBT) from digital mammography (DM). Thus, the breast imaging market is continuously growing due to largely consolidated players dominating ~45%-50% of the market share in 2018. The DBT is being highly publicized for effective breast imaging in order to reduce the incidences of false positives.

Analysts’ Viewpoint

The analysts anticipate that improved radiologist-patient communication is building the credibility of hospitals and clinics, thus making breast imaging widely accepted in developing economies of Asia Pacific. The breast imaging market is undergoing transformation with the introduction of AI and ML in early detection of lesions.

Moreover, DBT is gaining popularity over DM as a powerful tool for breast cancer screening. However, the volume of published data on DBT is limited to only first round of screening, thus creating ambiguity about the performance of the DBT over prolonged periods of time. Hence, companies should increase their efficacy in five-year research studies and more to create the availability of enough clinical data about DBT in order to establish its widespread application.

Breast Imaging Market: Overview

Breast imaging techniques involve capturing of images of breast tissues that assist in diagnosis and screening of breast cancer. Various technologies that are used to image breast tissues include mammography, breast MRI, breast ultrasound, and molecular imaging.

Mammography is considered as a standard technique to screen breast tissues. Breast MRI and breast ultrasound are used in combination with mammography for detailed and clear imaging of breast tissues.

The breast imaging market has experienced tremendous growth in the past decade, due to factors such as increased awareness about benefits of early breast cancer detection and high prevalence of breast cancer

Different types of technologies are used in breast imaging, including ionizing breast imaging and nonionizing breast imaging

Breast Imaging Market: Drivers

High Incidence of breast cancer and aging demographics are projected to boost the growth of the breast imaging market. According to the World Health Organization (WHO) statistics published in December 2018, 2.1 million new cases were diagnosed with breast cancer in 2018, which is 11.6% of the total cancer incidence burden. Breast cancer was the cause of death of 627,000 women globally in 2018. Out of 184 countries in the world, breast cancer is frequently diagnosed in 140 countries.

According to the World Cancer Research Fund, the number of breast cancer cases is likely to reach to 2.1 million by 2030

One of the major factors influencing the growth of this industry is increasing government initiative to increase awareness about breast cancer. Under the NBCCEDP, CDC offers mammograms and pap tests free of cost or at low price to those women who have low income and little or no insurance coverage. In order to encourage breast screening in the country, the U.S. Government passed the Breast and Cervical Cancer Mortality Prevention Act of 1990.

Purchase Complete Report Now@

Market Segmentation: Breast Imaging Market

Based on technology, the global breast imaging market has been divided into ionizing breast imaging (mammography, positron emission tomography-computed tomography (PET-CT), and molecular breast imaging (MBI)); nonionizing breast imaging (breast ultrasound, breast MRI, breast thermography, and automated whole-breast ultrasound (AWBU)); and others

In terms of end user, the global market has been categorized into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and research centers

Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments from 2018 to 2028, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2028 along with market size estimations.

Regional Overview: Breast Imaging Market

In terms of region, the global breast imaging market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

The current and future market value in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2028, with their CAGRs from 2020 to 2028

The study also offers a list of recommendations, highlights, and useful insights of the market which would help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Breast Imaging Market: Major Players

The report concludes with the company profiles section that includes key information about major players in the market

Leading players analyzed in the report include 

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Hologic, Inc.
  • Siemens Healthineers
  • Fujifilm Holding Corporation
  • Canon Medical Systems Corporation
  • Aurora Imaging Technologies, Inc.
  • Dilon Technologies, Inc.,
  • Leica Biosystems Nussloch GmbH (Danaher).

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Questions Answered in Breast Imaging Market Report

  • What is the sales/revenue generated by breast imaging products across all regions during the forecast period?
  • What are the opportunities in the breast imaging market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2028? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Breast Imaging Market – Segmentation


  • Ionizing Breast Imaging
  • Mammography
  • Analog Mammography
  • Digital Mammography
  • Positron Emission Tomography-Computed Tomography (PET-CT)
  • Molecular Breast Imaging (MBI)
  • Nonionizing Breast Imaging
  • Breast Ultrasound
  • Breast MRI
  • Breast Thermography
  • Automated Whole-breast Ultrasound (AWBU)
  • Others

End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Research Centers


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Research Methodology

3. Executive Summary

3.1. Global Breast Imaging Market Snapshot

4. Market Overview

4.1. Product Overview

4.2. Key Industry Events

4.3. Market Dynamics

4.4. Drivers and Restraints Snapshot Analysis

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunities

4.5. Global Breast Imaging Market Revenue Projection

4.6. Global Breast Imaging Market Outlook

5. Market Outlook

5.1. Breast Cancer Incidence and Mortality Rate, by Region in 2018

5.2. Global Risk of Breast Cancer

5.3. Top Three Players Operating in the Market Space

6. Global Breast Imaging Market Analysis, by Technology

6.1. Introduction

6.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

6.3. Global Breast Imaging Market Forecast, by Technology

6.3.1. Ionizing Breast Imaging Mammography Analog Mammography Digital Mammography Positron Emission Tomography-Computed Tomography (PET-CT) Molecular Breast Imaging (MBI)

6.3.2. Non-ionizing Breast Imaging Breast Ultrasound Breast MRI Breast Thermography Automated Whole-breast Ultrasound (AWBU)

6.3.3. Others

6.4. Global Breast Imaging Market Analysis, by Technology

7. Global Breast Imaging Market Analysis, by End-user

7.1. Introduction

7.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

7.3. Global Breast Imaging Market Forecast, by End-user

7.3.1. Hospitals & Clinics

7.3.2. Diagnostic Centers

7.3.3. Ambulatory Surgical Centers

7.3.4. Research Centers

7.4. Global Breast Imaging Market Analysis, by End-user

8. Global Breast Imaging Market Analysis, by Region

8.1. Global Breast Imaging Market Scenario, by Country

8.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by Region

8.3. Global Breast Imaging Market Forecast, by Region

8.3.1. North America

8.3.2. Europe

8.3.3. Asia Pacific

8.3.4. Latin America

8.3.5. Middle East & Africa

9. North America Breast Imaging Market Analysis


Purchase Complete Report Now@

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us: